InMode Ltd. (INMD): Operating Cash Flow
$85.26M
Year ended 2025-12-31
-22.3%
3-year compound annual growth
+1.5%
5-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $85.26M | -35.7% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $132.66M | -25.0% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $176.83M | -2.6% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $181.58M | +3.8% | 2025-02-04, From 2022-01-01 |
| 2021-12-31 | $174.88M | +120.7% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $79.22M | +27.4% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $62.21M | +68.6% | 2022-02-10, From 2019-01-01 |
| 2018-12-31 | $36.89M | +152.5% | 2021-02-10, From 2018-01-01 |
| 2017-12-31 | $14.61M | n/a | 2020-02-18, From 2017-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| InMode Ltd. (INMD) | 2025-12-31 | $85.26M | -35.7% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $192.84M | +295.1% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $812.0K | -82.1% |
| Outset Medical, Inc. (OM) | 2025-12-31 | -$46.33M | n/m |
| Conmed Corp (CNMD) | 2025-12-31 | $170.69M | +2.2% |
| LivaNova PLC (LIVN) | 2025-12-31 | $254.34M | +39.0% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $20.11M | +138.6% |
| Vaso Corp (VASO) | 2025-12-31 | $9.27M | +182.6% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | -$40.81M | n/m |
Compare INMD, TMDX, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗